Oral Insulin: Next Steps
Pursue development with a formulated tablet
Partner program to expedite design and execution of development work
Maximize the long-term drivers of value
- Clinical data generated from U.S. Phase I studies
- Presentations at technical conferences
- Patents
Multi-dose study (Profil Institute, Germany)
- Single-center, double-blind, randomized, controlled, parallel-group study in diet-controlled Type 2 diabetic patients
- Screening, treatment and follow up phase to assess safety and efficacy
- Dose based on tablet prototype study